BSECompany Update5d ago · 8 Aug 2026, 07:12 pm

Intimation of Earnings Conference Call for the quarter Q1 of FY27.

Fredun Pharmaceuticals Ltd · 539730

✦ AI SummaryResults

Fredun Pharmaceuticals Ltd will host an earnings conference call on August 13, 2026, to discuss Q1 FY27 results.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

f0f9ad78-f503-424f-9ad2-fb86ce1527af.pdf

pdf

Download →
View document text
Date: 08th August, 2026 BSE Limited Listing Department, Phiroze Jeejeebhoy Towers, Dalal Street - Fort, Mumbai - 400 001. Scrip Code - 539730 Sub: Intimation of Earnings Conference Call for the quarter Q1 of FY27. Dear Sir / Madam, Pursuant to Regulation 30 read with sub para 15, Para A Part A Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that Company will host an Earnings Conference call on Thursday, 13th August, 2026 at 11:30 a.m. Earnings Conference Call Dial-In Information: Registration Link CLICK HERE FOR REGISTRATION Dial-In Numbers +91 22 6280 1239 +91 22 7115 8140 Kindly oblige and take the same on your Records. Thanking you, For Fredun Pharmaceuticals Limited Fredun Medhora Managing Director DIN: 01745348 Kirin Advisors Cordially invite you to the Q1 FY27 Earnings Call of Fredun Pharmaceuticals Limited Thursday 13th August, 2026 11:30 AM Onwards Joining Details Universal Dial In +91 22 6280 1239 +91 22 7115 8140 DIAMOND PASS LOGIN CLICK HERE TO REGISTER Note: When using dial-in numbers mentioned above please do so 10 minutes prior to the conference schedule to ensure that you are connected to your call in time. Speakers From Management Mr. Fredun Medhora Managing Director For More Information +91 22 4100 2455 research@kirinadvisors.com 713-B Lodha Supremus II, Wagle www.kirinadvisors.com +91 93244 75886 info@kirinadvisors.com Estate, Thane (W) 400 604 Disclaimer: Certain statements that may be made or discussed at the conference call may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like significant changes in economic environment in India and abroad. Actual results might differ substantially from those expressed or implied. The company and its Management will not be in any way responsible for any action taken based on such statements and discussions.